2017 China New Design Sodium Citrate Dihydrate - Bedside Leukocyte Reduction Filter – Zhongbaokang Medical
Short Description:
Product Detail
Product Tags
Related Video
Feedback (2)
2017 China New Design Sodium Citrate Dihydrate - Bedside Leukocyte Reduction Filter – Zhongbaokang Medical Detail:
Usage:
Our Leukocyte Removal Filters(bedside) is designed to remove the leukocytes and micro-aggregate in blood and protect patients from leukocyte-related transfusion complications such as GVHD diseases and adverse reactions etc.
Property:
Residual WBC count less than≤1.0×106/unit
High RBC recovery rate≥90%
Hematolysis rate≤5%
100%removal of micro-aggregates
Structure:
It consists of a pre-filtration, filter, the pipelines, air filter.
1.Pre-filtration will remove micro-aggregate in the blood, and prevent the bubble entering the main filter
2.The filter is the core part where the leukocytes can be filtered and absorbed.
3.The pipelines consist of the saline solution pipeline and the blood pipeline. By irrigating the pipelines with saline solution after filtration, the red blood cells in the pipelines can be recovered thoroughly.
4. Air Filter will prevent the particles into the filter kit.
Sterilization:ETO
Certificate:CE, ISO9001, ISO14001, IS013485
Product detail pictures:
Related Product Guide:
Global Venous Blood Collection Devices Market Is Anticipated to Expand at 9.3% CAGR From 2017 To 2023 | Light Senstive Infusion Set
ExThera Medical Announces Completion of CE Mark Registration Trial Evaluating the Safety of Seraph® 100 Blood Filter | Light Senstive Infusion Set
2017 China New Design Sodium Citrate Dihydrate - Bedside Leukocyte Reduction Filter – Zhongbaokang Medical, The product will supply to all over the world, such as: , , ,
By from -
By from -
